Persistent CD30 Expression by Embryonal Carcinoma in the Treatment Time Course: Prognostic Significance of a Worthwhile Target for Personalized Treatment

Author:

Giannatempo Patrizia1,Paolini Biagio2,Miceli Rosalba3,Raggi Daniele1,Nicolai Nicola4,Farè Elena1,Catanzaro Mario4,Biasoni Davide4,Torelli Tullio4,Stagni Silvia4,Piva Luigi4,Mariani Luigi3,Salvioni Roberto4,Colecchia Maurizio2,Gianni Alessandro Massimo15,Necchi Andrea1

Affiliation:

1. Department of Medical Oncology, Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico Istituto Nazionale dei Tumori, Milan, Italy

2. Department of Pathology, Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico Istituto Nazionale dei Tumori, Milan, Italy

3. Clinical Epidemiology and Trials Organization Unit, Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico Istituto Nazionale dei Tumori, Milan, Italy

4. Department of Surgery (Urology Unit), Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico Istituto Nazionale dei Tumori, Milan, Italy

5. University of Milan School of Medicine, Milan, Italy

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference21 articles.

1. Medical treatment of advanced testicular cancer;Feldman;JAMA,2008

2. The conudrum of clinical trials in adult germ-cell tumors;Powles;Lancet Oncol,2013

3. CD30 in normal and neoplastic cells;Chiarle;Clin Immunol,1999

4. CD30 expression in follicular lymphoma;Gardner;Arch Pathol Lab Med,2001

5. CD30: an important new target in hematologic malignancies;Deutsch;Leuk Lymphoma,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3